Pentwater Capital Management LP - Jun 30, 2025 SCHEDULE 13G Report for Verve Therapeutics, Inc. Common Stock, par value $0.001 per share (VERV)

Filing Manager
Pentwater Capital Management LP
Reporting Manager
Pentwater Capital Management LP
Security
Verve Therapeutics, Inc. Common Stock, par value $0.001 per share
Symbol
VERV
Shares outstanding
89.6M shares
Disclosed Ownership
6.72M shares
Ownership
7.5%
Form type
SCHEDULE 13G
Date filed
8/14/2025, 04:08 PM
Date of event
Jun 30, 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Pentwater Capital Management LP 7.5% 6.72M 0 6.72M /s/ Matthew Halbower By: MCH PWCM Holdings Inc., General Partner, By: Matthew Halbower, Chief Executive Officer
Matthew Halbower 7.5% 6.72M 0 6.72M /s/ Matthew Halbower Matthew Halbower, Individually